Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Human hemopoietic growth factors.

¹Institute for Clinical Immunology and Rheumatology, University of Erlangen-Nuremberg, Fed. Rep. Germany.

European Journal of Haematology

|January 1, 1989

Summary

This review explores new developments in hemopoietic growth factors, crucial for regulating blood cell formation. These factors show promise for treating conditions with insufficient hematopoiesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Randomized, controlled, dose-range study of Ro 25-8315 given before and after a high-dose combination chemotherapy regimen in patients with metastatic or recurrent breast cancer patients.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2002

Same author

Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: comparison with single and multiple daily doses of filgrastim.

American journal of hematology·2001

Same author

Filgrastim (r-metHuG-CSF): the first 10 years.

Blood·1996

Same author

Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1994

Same author

Differential effects of transferrin receptor antibodies on growth and receptor expression of human lymphocytic and myelocytic cell lines.

European journal of haematology·1994

Same author

Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy.

Blood·1993

Area of Science:

Hematology
Molecular Biology
Biochemistry

Background:

Hematopoiesis, the process of blood cell formation, is intricately regulated by soluble factors and the bone marrow microenvironment.
Advancements in molecular biology and protein biochemistry have yielded significant quantities of hemopoietic growth factors.
These growth factors are vital for understanding and potentially treating various causes of insufficient hematopoiesis.

Purpose of the Study:

To review recent advancements in understanding the activity of hemopoietic growth factors.
To present updated clinical data regarding the application of these factors.
To highlight the therapeutic potential of hemopoietic growth factors for patients with hematopoiesis disorders.

Main Methods:

Literature review of recent scientific publications.
Analysis of molecular and biochemical data on hemopoietic growth factors.
Synthesis of current clinical findings and trial results.

Main Results:

New insights into the complex regulatory network of hematopoiesis have emerged.
Availability of purified hemopoietic growth factors facilitates extensive research.
Promising clinical outcomes are being observed in patients with insufficient hematopoiesis.

Conclusions:

Hemopoietic growth factors represent a significant therapeutic avenue for hematological disorders.
Continued research is essential to fully elucidate their mechanisms and optimize clinical use.
These factors hold considerable promise for improving patient outcomes in conditions characterized by inadequate blood cell production.

Related Experiment Videos